维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="ALONCI A"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases 显示文摘	Alonci A Allegra A Bellomo G	2008	Hematol Oncol2008，26，4：	1
2	Bisphospbonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws显示文摘	Allegra A Alonci A Penna G	2010	Acta Haematol2010，124，2：	1
3	JAK2 V617F-positive latent essential thrombocythemia and splanehnic vein thrombosis:the role of bone marrow biopsy for the diagnosis of myeloproliferative disease 显示文摘	ALLEGRA A ALONCI A PENNA G	2009	Acta Haematol2009，121，4：	1
4	Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response显示文摘	Alonci A Allegra A	2002	Br J Haemotol2002，94，：	1
5	Differential levels of soluble angiopoietin-2 and Tie-2 in patients with haematological malignancies显示文摘	Quartarone E Alonci A Allegra A	2006	Eur J Haematol2006，77，6：	1
6	Levels of soluble angiogenin in chronic myeloid malignancies:clinical implications显示文摘	Musolino C Alonci A	2004	Eur J Haematol2004，72，6：	1
7	Differential levels of soluble angiopoietin-2 and Tie-2 in patients with haematological malignancies显示文摘	QUARTARONE E ALONCI A ALLEGRA A	2006	Eur J Haematol2006，77，：	1
8	Evaluation of circulation endothelial cells,VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases显示文摘	Alonci A Allegra A Bellomo G	2008	Hematol Oncol2008，26，2：	1
9	Circulating microRNAs:new biomarkers in diagnosis,prognosis and treatment of cancer(review)显示文摘	Allegra A Alonci A Campo S	2012	Int J Oncol2012，41，6：	1
10	Imatinib mesylate treatment in a patient with chemoresistant Ph+ acute myeloid leukemia: possible role of tumor gene 1 显示文摘	Quartarone E Allegra A Alonci A	2007	Tumori2007，93，：	1
11	JAK2V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis the role of bone marrow biopsy for the diagnosis of myeloproliferative disease显示文摘	Allegra A Alonci A Penna G	2009	Acta Hematol2009，121，4：	1
12	New orally active proteasome inhibitors in multiple myeloma显示文摘	Allegra A Alonci A Geraee D	2014	Leuk Res2014，38，1：	1
13	The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets 显示文摘	Allegra A Alonci A Penna G	2014	Cancer Invest2014，32，9：	1
14	Differential levels of aoluble angiopoietin - 2 and Tie - 2 in patients with haematological malignancies 显示文摘	QUARTARONE E ALONCI A ALLEGRA A	2006	Eur J Haematol2006，77，6：	1
15	The cancer stem cell hypothe- sis : a guide to potential molecular targets 显示文摘	Allegra A Alonci A Penna G	2014	Cancer Invest2014，32，9：	1
16	Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B显示文摘	Allegra A Penna G Alonci A	2009	Med Oncol2009，9，23：	1
17	Levels of soluble angiogenin in chronic myeloid malginancies: clinical implications显示文摘	Musolino C Alonci A Bellomo G	2004	Eur J Haematol2004，72，6：	1
18	Exacerbation of chronic id- iopathic thrombocytopenic purpura following reactivation of an oc- cult hepatitis B 显示文摘	Allegra A Penna G Alonci A	2010	Medical Oncology2010，27，3：	1
19	Evaluation of circulation endothelial cells,VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases显示文摘	Alonci A Allegra A Bellomo G	2008	Hematologicaloncology2008，26，2：	1
20	Differential levels of soluble angiopoietin-2 and Tie-2 in patients with haematological malignancies显示文摘	Quartarone E Alonci A Allegra A	2006	Eur J Haematol2006，77，6：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示